Identifying Genes for Mutations in Mesothelioma Research

Another interesting study is called, "Immunohistochemical Analysis of the p16INK4 Cyclin-Dependent Kinase Inhibitor in Malignant Mesothelioma" - JNCI J Natl Cancer Inst (1995) 87 (24): 1870-1875 by Robert A. Kratzke, Gregory A. Otterson, Clint E. Lincoln, Stephen Ewing, Herbert Oie, Joseph Geradts and Frederic J. Kaye. Here is an excerpt: "Abstract - Background: The identification in 1994 of the CDKN2 gene as a target for mutations in a wide range of human cancers, including malignant

Mesothelioma